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Abstract
Micro-emulsions are isotropic, thermodynamically stable transparent (or translucent) systems of oil, water, and surfactant with a droplet size 
usually in the range of 20-200 nm. Micro-emulsions are currently of great technological and scientific importance to the researchers because of 
their potential to incorporate a wide range of drug molecules (hydrophilic and hydrophobic) due to the presence of both lipophilic and hydrophilic 
domains. These delivery systems provide protection against oxidation, enzymatic hydrolysis and improve the solubilization of lipophilic drugs 
and hence enhance their bioavailability. In addition to oral and intravenous delivery, they are amenable for sustained and targeted delivery 
through ophthalmic, dental, pulmonary, vaginal, and topical routes. They have been used to improve the oral bioavailability of various poorly 
soluble drugs. Furthermore, they can be employed for challenging tasks such as carrying chemotherapeutic agents to neo-plastic cells and oral 
delivery of insulin. In order to appreciate the potential of micro-emulsions as delivery vehicles, this review gives an overview of the formation and 
characterization of microemulsions. The use of microemulsions and closely related micro-emulsion-based systems as drug delivery vehicles is 
reviewed, with particular emphasis being placed on recent developments and future directions.
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Introduction
there are distinct differences in their method of preparation, since 
emulsions require a large input of energy while microemulsions do 
not. The latter point has obvious implications when considering 
the relative cost of commercial production of the two types of 
system. 
Micro-emulsion is homogeneous, transparent, thermodynamically 
stable dispersions of water and oil, stabilized by a surfactant, 
usually in combination with a co-surfactant. In this type of system, 
1-5 the two liquids tend to separate out in two layers,  and to avoid 
this, a third substance called as an emulsifier is added which is, in 
general, surface-active agent or surfactant. Surfactant molecules 
contain both a polar and a nonpolar group. So they exhibit a very 
peculiar behavior, first, they tend to adsorb at interface, where they 
can  fulfill  their  dual  affinity  with  hydrophilic  groups  located  in 
aqueous phase and hydrophobic groups in oil or air. Second, they 
reduce  the  mismatch  with  solvent  through  a  specific  kind  of 
aggregation process known as micellization.
The micro-emulsion concept was introduced as early as the 1940s 
by Hoar and Schulman who generated a clear single-phase solution 
6 by  titrating  a  milky  emulsion  with  hexanol.   Schulman  and 
7 coworkers (1959) subsequently coined the term micro-emulsion,  
and  it  has  since  been  defined  and  indeed  redefined  on  many 
occasions. In practice, the key difference between emulsions and 
micro-emulsions  are  that  the  former,  whilst  they  may  exhibit 
excellent kinetic stability, are fundamentally thermodynamically 
8-9 unstable,  and  will  eventually  solphase  separate. Another 
important  difference  concerns  their  appearance;  emulsions  are 
cloudy while microemulsions are clear or translucent. In addition, 
Advantages of Microemulsion
Microemulsions are potential drug carrier systems for various 
6  routes of administration. These are having advantages when 
compare to the other dosage forms. 
These  are  thermodynamically  stable  and  require  minimum 
energy for formation. 
Ease of manufacturing and scale-up 
Improved drug solubilisation and bioavailability. 
This system is reckoned advantageous because of its wide 
applications in colloidal drug delivery systems for the purpose 
of drug targeting and controlled release. 
Liquid dosage form increases patient compliance.
Provides protection from hydrolysis and oxidation as drug in oil 
phase in O/W microemulsion is not exposed to attack by water 
and air.
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Various routes like tropical, oral and intravenous can be used to 
deliver the product.
Provides a aqueous dosage form for water insoluble drugs.
Less amount of energy requirement.
Increase the rate of absorption.
Microemulsion is having wide applications in colloidal drug 
delivery systems for the purpose of drug targeting and controlled 
release.
Theory of Microemulsion Formation
ΔGF=γΔA-TΔS
Where, ΔGF= free energy of formation;   = surface tension of oil-
water  interface;  ΔA=the  change  in  interfacial  area  on 
microemulsion; ΔS = change in entropy; T = temperature.
It should be noted that when a micro-emulsion is formed the change 
in ΔA is very large due to the large number of very small droplets 
formed. Originally workers proposed that in order for a micro-
emulsion to be formed a negative value of   
is positive at all times, it is very 
small  and  is  offset  by  the  entropic  component.  The  dominant 
favorable entropic contribution is the very large dispersion entropy 
arising from the mixing of one phase in the other in the form of large 
numbers of small droplets. However, there are also expected to be 
favorable  entropic  contributions  arising  from  other  dynamic 
processes such as surfactant diffusion in the interfacial layer and 
monomer-micelle surfactant exchange. Thus a negative free energy 
of formation is achieved when large reductions in surface tension 
are accompanied by significant favorable entropic change. In such 
cases,  micro-emulsification  is  spontaneous  and  the  resulting 
dispersion is thermodynamically stable.
γ
γ was required, it is now 
recognized that while value of γ 
Characterization 
In contrast to their ease of preparation, it is a far from trivial matter 
to characterize the microstructure of a micro-emulsion, yet such 
knowledge  is  essential  for  their  successful  commercial 
exploitation.  For  example,  it  has  been  shown  that  the  rate  of 
Historically,  three  approaches  have  been  proposed  to  explain 
microemulsion formation and stability. These are (a) interfacial or 
mixed film theory; (b) solubilisation theory; and (c) thermodynamic 
treatments. 
An in depth discussion of these theories are beyond the scope of 
10 this  review  but  has  been  addressed  by  others.   However,  an 
admittedly simplified thermodynamic rationalization is presented 
below.  The  free  energy  of  micro-emulsion  formation  can  be 
considered to depend on the extent to which surfactant lowers the 
surface tension of the oil–water interface and the change in entropy 
of the system such that,
release of sodium salicylate from lecithin-based micro-emulsions 
11 is dependent upon their microstructure.  The micro-emulsions are 
evaluated /characterized by the following techniques:
Phase behavior studies
Visual  observations,  phase  contrast  microscopy,  and  freeze 
fracture  transmission  electron  microscopy  can  be  used  to 
differentiate  micro-emulsions  and  coarse  emulsions.  Clear 
isotropic one-phase systems are identified as micro-emulsions 
whereas opaque systems showing bifringence when viewed by 
cross polarized light microscopy may be taken as liquid crystalline 
system.  Solubilisation  and  interfacial  properties  of  micro-
emulsions depend upon pressure, temperature and also on the 
nature and concentration of the components. Several types of 
phase diagram can be identified depending on the number of 
variables involved. In using an adequate mode of representation, it 
is possible to describe not only the limits of existence of the single 
and  multiphase  regions,  but  also  to  characterize  equilibrium 
between phases. As quaternary phase diagram (four component 
system)  is  time  consuming  and  difficult  to  interpret,  pseudo 
ternary phase diagram is often constructed to find the different 
zones including micro-emulsion zone, in which each corner of the 
diagram represents 100% of the particular component Fig. 1. The 
region can be separated into w/o or o/w micro-emulsion by simply 
considering the composition that is whether it is oil rich or water 
rich. Observations should be made carefully so that the metastable 
systems are not included.
Fig.1:  Schematic representation of a two-arm randomized clinical 
trial of new and existing anti-HT treatments in HT patients with 
one or more additional risk factors
Determination of internal structure
Transmission (TEM) and scanning (SEM) techniques have been 
used to study internal and surface mesophase nanostructure. The 
general approach to TEM analysis is to prepare a sample as a thin 
film, such that an electron beam can pass through it. The image is 
collected with contrast resulting from differential absorption and 
scattering of electrons from different regions of the sample. As 
with all electron microscope based techniques, imaging artefacts 
due  to  sample  preparation  and  dehydration  are  a  major 
consideration.  This  has  led  to  the  development  of  cryogenic 
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12  preparation (cryo-TEM) and freeze-fracture (FFEM) techniques.
Viscosity measurement
The rheological properties of micro-emulsions depend on the type, 
shape and number density of aggregates present, as well as the 
interactions  between  these  aggregates.  Hence,  microstructural 
changes  such  as  sphere-rod  or  discontinuous  to  bicontinuous 
transitions are reflected in micro-emulsion rheology. Bicontinuous 
microemulsions exhibit a Newtonian behavior (constant viscosity) 
at low to medium shear rates but shear thinning is observed at high 
shear rates, probably due to fragmentation of the bicontinuous 
structure. Discontinuous microemulsions on the other hand show 
Newtonian behavior over a wider range of shear rates. However, 
differentiation of the types of microemulsions or identification of the 
structure of the microemulsion cannot be done purely on the basis 
of  rheological  data,  because  this  macroscopic  property  is  not 
sensitive enough to detect subtle microstructural changes such as 
the transformation of microemulsion to a wormlike micellar phase 
induced by temperature. Hence, rheometry has most often been 
used in combination with other techniques in the characterization of 
microemulsions. 
Electrical conductivity measurement
Electrical conductivity remains a simple and inexpensive technique 
for microemulsion characterization. It primarily reveals whether an 
aqueous  or  oil  phase  or  both  phases  are  continuous.  The 
conductivity measurement technique has been used to determine 
the  type  of  microemulsion,  and  to  estimate  phase  boundaries 
resulting from changes in composition or temperature 
In-vitro drug release study
The diffusion study can be carried out on a modified Franz diffusion 
cell. The receptor compartment was filled with buffer. The donor 
compartment was fixed with cellophane membrane containing 
the micro-emulsion formulation. At predetermined time intervals 
samples were withdrawn from the receptor compartment and 
analyzed  for  drug  content,  using  a  UV  spectrophotometer  at 
specific wavelength.
Ex-vivo drug release study
Ex-vivo  drug  release  into  buffer  was  studied  using  intestinal 
membrane  within  a  Franz  diffusion  cell.  Micro-emulsion 
formulation was placed in the donor compartment of two separate 
diffusion cells and the temperature of each cell was maintained at 
37±2°C. The amount of drug released from the micro-emulsion 
formulation can be estimated spectrophotometrically at specific 
wavelength,  by  withdrawing  samples  from  the  receptor 
13 compartment at predetermined time intervals.
The  development  of  the  effective  oral  delivery  systems  has 
always been the main goal because drug efficacy can be severely 
limited by instability or poor solubility in the gastrointestinal fluid. 
Biopharmaceutical  Classification  System  (BCS)  is  a  useful 
guidance and it takes into account contributions of three major 
factors, dissolution, solubility, and intestinal permeability, which 
affect  oral  drug  absorption.  According  to  the  BCS,  drug 
14 substances are classified as follows:  Class I - High Permeability, 
High Solubility; Class II - High Permeability, Low Solubility; Class III 
- Low Permeability, High Solubility; Class IV - Low Permeability, 
Low Solubility. Various approaches of solubility enhancement are 
shown in Fig. 2.
Development of microemulsion drug delivery system
Oral drug delivery system
Fig. 2: Some of the formulation approaches to improve the oral bioavailability of poorly water soluble drugs
Microemulsions
SMEDDS
Liposomes
Ploymeric nanoparticles
Solid lipid    nanoparticles
Solid dispersions Use of surfactants
Formulation approaches to 
improve the oral bioavailability Cyclodextrins
Nano- and Micro-
suspensions Co-solvents Salt formation
Liquid based 
formulations
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Micro-emulsions have the potential to enhance the solubilization of 
the  poorly  soluble  drugs  and  overcome  the  dissolution  related 
bioavailability problems. This is particularly important for the BCS 
class II or class IV drugs. The successful formulation of such drugs 
is highly dependent on the performance of the formulated product. 
Micro-emulsions act as super solvent of these drugs and can be 
optimized to ensure consistent bioavailability. In addition, they can 
be  used  for  the  delivery  of  hydrophilic  drugs  including 
macromolecules such as proteins and peptides. This is due to the 
existence of polar, nonpolar, and interfacial domains which allow 
encapsulation of drugs with varying solubility.   Moreover, these 
systems have been reported to protect the incorporated drugs 
against  oxidation,  enzymatic  degradation  and  enhance  the 
membrane permeability.  
Parenteral drug delivery 
The formulation of lipophilic and hydrophobic drugs into parenteral 
dosage forms has proven to be difficult. O/w microemulsions are 
beneficial in the parenteral delivery of sparingly soluble drugs where 
the administration of suspension is not desirable. They provide a 
means of obtaining relatively high concentration of these drugs 
which usually requires frequent administration. Other advantages 
are that they exhibit a higher physical stability in plasma than 
liposomes or other vesicles and the internal oil phase is more 
resistant against drug leaching. Several sparingly soluble drugs 
have  been  formulated  into  o/w  microemulsion  for  parenteral 
15-18 delivery.   Microemulsions  can  also  be  used  as  intravenous 
delivery systems for the fat soluble vitamins and lipids in parenteral 
19 nutrition.   Dennis  et  al.  studied  an  intravenous  microemulsion 
delivery system for water insoluble or sparingly water   soluble 
drugs that comprised an oil phase comprising the   drug, a long 
polymer chain surfactant (e.g. lecithin, gelatin   casein, tweens, 
macrogol ethers, etc.) component and a short  fatty acid surfactant 
(e.g. stearic acid, glyceryl monostearate, sorbitan esters, etc.) 
20 component and an aqueous phase.   The droplet size ranged from 
10-100 nm. 
According  to  the  invention  of  the  Wretlind  et  al.  parenteral 
administration  of  water-insoluble  active  agents  was  enhanced 
when the agents were administered in the lipoid phase of a carrier 
21 microemulsion.   The  microemulsion  comprised  of  a  finely 
dispersed lipoid in an aqueous phase with a mean particle size 
below 1 micron. Higher concentration of the agent (diagnostic or 
therapeutic) could be achieved and hence a lower dose whereby a 
rapid onset of the pharmacological effect was accompanied by a 
reduced incidence of injury to body tissues. As the agents were 
present in a dissolved state in the hydrophobic phase, there was no 
need of affecting the pH or the osmotic pressure of the aqueous 
phase. Because of this, the method of administration according to 
the invention would cause a lower occurrence of injuries to the body 
tissues.
Pulmonary drug delivery system
Very few emulsions or micro-emulsions have been studied to 
administer drugs by the pulmonary route. However, these dosage 
forms  show  numerous  advantages  compared  to  other  drug 
targeting systems: easiness to be manufactured and maximum of 
drug to be incorporated. Indeed, the drug being soluble into one 
phase,  this  one  will  be  located  preferentially  into  this  phase, 
leading  to  an  encapsulation  close  to  100%.  Due  to  their 
physicochemical characteristics, reverse emulsions and micro-
emulsions should allow solubilization of a large amount and a lot of 
22 hydrophilic drugs.  Several aerosol formulations designed with an 
external phase constituted of a propellant have been described. As 
example,  one  can  cite  water-in-chlorofluorocarbon  reverse 
23 micelles including proteins and peptides stabilized by lecithin.  
Even if this dosage form is stable and is able to deliver peptides and 
proteins efficiently by pulmonary route, its use should be limited 
since the Montreal protocol (1987) recommended stopping the 
production and the use of chlorofluorocarbons. Propellants like 
hydrofluoroalkanes  or  propane  have  been  suggested.  Reverse 
micro-emulsions stabilized by lecithin and using propane and di-
24 methylether  as  propellants  have  been  also  described.   These 
micro-emulsions,  characterized  by  mean  geometric  diameters 
ranged between 1 and 5 μm and by a respirable fraction up to 36%, 
showed  high  stability  during  more  than  4  weeks  at  room 
temperature. Pulmonary drug delivery having very negligible side 
effects since rest of body is not exposed to drug. Onset of action is 
very quick with pulmonary drug delivery. Degradation of drug by 
liver is avoided in pulmonary drug delivery. In asthma and diabetes 
requires long term treatment if it is given by pulmonary drug 
delivery safety is maximal because rest of body is not exposed to 
drug.
Ocular drug delivery system
Eye drops account for 90% of the available ophthalmic formulations 
due to their simplicity and convenience. However, rapid precorneal 
loss caused by drainage and high tear fluid turnover is amongst the 
major problems associated with topical ophthalmic drug delivery. 
Only 5% of the applied drug in eye drops penetrates the cornea and 
reaches  the  intraocular  tissues  with  the  rest  of  the  dose 
undergoing  transconjunctival  absorption  or  drainage  via  the 
nasolacrimal duct before transnasal absorption. This results in loss 
of drug into the systemic circulation and provides undesirable 
systemic side effects. Accordingly, microemulsions provided a 
promising alternative with improved ocular retention, increased 
corneal drug absorption and reduced systemic side effects whilst 
maintaining the simplicity and convenience of the dosage form as 
eye drops. The development and characterization of o/w micro-
25 emulsions designed for ocular use has recently been reported.  
The  micro-emulsions  containing  pilocarpine  were  formulated 
using lecithin, propylene glycol and PEG 200 as co-surfactants. 
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The formulations were low viscosity fluids with a refractive index 
lending  them  to  ophthalmological  application.  The  test  micro-
emulsions were non-irritant in rabbit eyes or hen egg membrane. A 
prolonged pharmacological effect was observed in vivo compared 
to the drug administered as a simple aqueous solution. This may 
have been related to increased bioavailability or enhanced retention 
or both. However, prolonged release was not observed in vitro using 
a cellulose membrane as permeability barrier.
Transdermal drug delivery system 
Several plausible mechanisms have been proposed to explain the 
advantages of micro-emulsion for the transdermal delivery of a 
drug:
A large amount of drug can be incorporated in the formulation 
due  to  the  high  solubilizing  capacity  that  might  increase 
thermodynamic activity towards the skin.
The permeation rate of the drug from micro-emulsion may be 
increased, since the affinity of a drug to the internal phase in 
micro-emulsion can be easily modified to favor partitioning into 
stratum corneum, using different internal phase, changing its 
portion in micro-emulsion.
The surfactant and co surfactant in the micro-emulsions may 
reduce the diffusional barrier of the stratum corneum by acting 
as penetration enhancers.
The percutaneous absorption of drug will also increase due to 
hydration effect of the stratum corneum if the water content in 
micro-emulsion is high enough.
A  number  of  recent  reports  detail  microemulsion  formulations 
designed  for  transdermal  applications.  Both  o/w  and  a  w/o 
microemulsions have been evaluated in a hairless mouse model for 
the delivery of prostaglandin E1. The microemulsions were based 
on oleic acid or Gelucire as the oil phase and were stabilized by a 
26 mixture of Labrasol and Plurol as surfactant.  Although enhanced 
delivery rates were observed in the case of the o/w microemulsion, 
the authors concluded that the penetration rates were inadequate 
for practical use from either system.
The  delivery  of  the  hydrophilic  diphenhydramine  hydrochloride 
through excised human has been investigated from a w/o type 
microemulsion. The formulation was based on combinations of 
Tween 80 and Span 20 with isopropylmyristate. However, two 
additional formulations were tested containing cholesterol and oleic 
acid, respectively. Cholesterol increased drug penetration whereas 
oleic  acid  had  no  measurable  effect,  but  the  authors  clearly 
demonstrated that penetration characteristics can be modulated by 
27 compositional selection.  
Protein drug delivery system
Numerous peptide and proteins have been identified for use as 
novel therapeutic agents. With increase in the understanding of 
their structure and mechanism, recent research has shifted to 
28 biotechnological  products.   Changing  scenario  and  increased 
market competitiveness is pressurizing companies to address 
significant protein delivery issues already at late discovery and 
early  development  stages.  However,  in  spite  of  tremendous 
advances in peptide and protein development, their delivery is 
limited  to  systemic  route.  This  is  due  to  their  low  oral 
bioavailability  which  can  be  ascribed  to  their  inactivation  by 
gastrointestinal enzymes and poor permeability of the intestinal 
mucosa.  To  circumvent  this,  micro-emulsions  have  been 
developed as smart systems and patented for the oral delivery of 
protein and peptide drugs.
One preferred embodiment of the invention of Burnside et al. 
comprised of a micro-emulsion containing an oil phase (such as a 
long chain carboxylic acid or ester or alcohol thereof), a surface 
active  agent  (such  as  a  poloxamer)  and  an  aqueous  phase 
29 containing  the  insulin.   They  had  attempted  to  increase  the 
intestinal absorption of the hormone which had met with only 
limited  success  earlier.  The  hydrophobic  material  formed  the 
continuous  phase  and  the  hydrophilic  material  formed  the 
discontinuous  phase  in  which  the  hydrophilic  material  was 
emulsified  (w/o).  A  large  amount  of  polar  solutes  could  be 
dissolved in an overall oily environment by using w/o micro-
emulsion thereby creating an oral delivery system for insulin.
Owen et al. provided a highly stable w/o micro-emulsion which 
readily converted to an o/w emulsion by the addition of aqueous 
30 fluid.  Proteins and peptides could be stored for long periods of 
time at room temperature and above by using the w/o micro-
emulsion. When required for use aqueous fluid was added which 
converted the micro-emulsion to an o/w emulsion and released 
the protein. 
Nasal drug delivery system
Micro-emulsions are now being studied as a delivery system to 
enhance  uptake  across  nasal  mucosa.  Addition  of  a 
mucoadhesive polymer helps in prolonging the residence time on 
the mucosa. Nasal route for administration of diazepam might be a 
useful approach for the rapid onset of action during the emergency 
treatment of status epilepticus. For this micro-emulsion were 
formulated  comprising  of  ethyl  laurate,  Tween  80,  propylene 
glycol, ethanol, and water. The nasal absorption of diazepam was 
found to be fairly rapid with maximum drug plasma concentration 
reached within 2-3 min. The bioavailability (0-2 h) after nasal spray 
31 compared to IV injection was about 50%.
Conclusion
To date micro-emulsions have been shown to be able to protect 
labile drug, control drug release increase drug solubility, increase 
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bioavailability, and reduce patient variability. Furthermore, it has 
proven possible to formulate preparations suitable for most routes 
of  administration.  The  use  of  micro-emulsion  as  drug  delivery 
vehicles is an exciting and attractive area of research, offering not 
only many challenges to be overcome but also many potentially 
extraordinary benefits. There is still however a considerable amount 
of fundamental work characterizing the physicochemical behavior 
of microemulsions that needs to be performed before they can live 
up to their potential as multipurpose drug delivery vehicles. 
References
1. Hoar TP, Schulman JH Transparent water in oil dispersions: the 
oleopathic hydromicelle. Nature 1943; 152:102-107. 
2. Solans C, Kunieda H. Industrial Applications of Microemulsions, New 
York, NY: Marcel Dekker, 1997. 
3. Kumar P, Mittal KL. Hand Book of Microemulsions: Science and 
Technology, New York, NY: Marcel Dekker, 1998. 
4. Moulik SP, Mukherjee K. On the versatile surfactant aerosol-OT and 
its physicochemical and surface chemical behaviors and uses. Proc 
Indian Natl Sci 1996; 62: 215-222. 
5. Paul BK, Moulik SP. Microemulsions: overview. J Disp Sci Technol 
1997; 118:301-367. 
6. Hoar TP, Schulman JH. Transparent water-in-oil dispersions: the 
oleopathic hydro-micelle. Nature 1943; 152: 102-103.
7. Ghosh PK, Murthy RS. Microemulsions: A potential drug delivery 
system. Curr Drug Deliv 2006; 3: 167-180.
8.  Shinoda  K,  Lindman  B.  Organized  surfactant  systems 
microemulsions, Langmuir 1987; 3: 135-149.
9. Prince LM. A theory of aqueous emulsion I: Negative interfacial 
tension at the oil /water interface. J Colloid Interface Sci 1967; 23: 165-
173.
10. Tadros TF. Microemulsions: An Overview. In: Mittal KL, Lindman B, 
ed.  Proc.  4th  International  Symposium.  Surfactants  in  Solution. 
Plenum: New York, 1984: 1501-1532.
11. Khoshnevis SA, Mortazavi MJ, Lawrence R. In-vitro release of 
sodium salicylate from water in-oil phospholipid microemulsions. J 
Pharm Pharmacol 1997; 49: 47-47.
12. Belkoura L, Stubenrauch C, Strey R. Freeze fracture direct imaging: 
a  new  freeze  fracture  method  for  specimen  preparation  in  cryo-
transmission electron microscopy. Langmuir 2004; 20:4391-4399.
13.  Von  Corswant  C,  Thoren  P,  Engstrom  S.  Triglyceride  based 
microemulsion  for  intravenous  administration  of  sparingly  soluble 
substances. J Pharm Sci 1998; 87:200-208.
14.  Kyung-Mi  P,  Chong-Kook  K.  Preparation  and  evaluation  of 
flurbiprofen-loaded microemulsion for parenteral delivery. Int J Pharm 
1999; 181:173-179. 
15.  Lee  JM,  Park  KM,  Lim  SJ,  Lee  MK,  Kim  CK.  Microemlsion   
formulation  of  clonixic  acid:  solubility  enhancement  and  pain   
reduction. J Pharm Pharmacol 2002; 54: 43-49. 
16.  Rhee  YS,  Park  CW,  Nam,  TY,  Shin  YS,  Chic  SC,  Park  ES.   
Formulation  of  parenteral  microemulsion  containing  itraconazole.   
Arch Pharm Res 2007; 30: 114-123. 
17. Ryoo HK, Park CW, Chi SC, Park ES. Development of propofol 
loaded micro-emulsion systems for parenteral delivery. Arch Pharm 
Res 2005; 28: 1400-1404. 
18. Hwang SR, Lim SJ, Park JS, Kim CK. Phospholipids' based micro 
emulsion formulation for all-trans-retinoic acid for parenteral. Int J 
Pharm 2004; 276: 175-183.
19.  Jumma  M,  Muller  BW.  The  effect  of  oil  components  and 
homogenization conditions on the physicochemical properties and 
stability of parenteral fat emulsions. Int J Pharm 1998; 163:81-89.
20.  Morey  TE,  Modell  JH,  Shekhawat  D,  Grand  T,  Shah  DO, 
Gravenstein N, McGorray SP, Dennis DM. Preparation and anesthetic 
properties of propofol microemulsions in rats. Anesthesiology 2006; 
104:1184-90.
21. Wretlind KA, Ljungberg S, Hakansson I, Ajaxon BM.  Composition 
for enhancing the administration of pharmacologically active agents. 
US Patent  4073943, 1976.
22. Lawrence MJ, Rees GD. Microemulsion-based media as novel 
drug delivery systems. Adv Drug Del Rev 2000; 45:89-121.
23. Evans RM, Farr SJ. Aerosol formulations including proteins and 
peptides solubilized in reverse micelles and process for making the 
aerosol formulations. US Patent 5230884A, 1993.
24. Sommerville ML, Cain JB, Johnson CS, Hickey AJ. Lecithin inverse 
microemulsions  for  the  pulmonary  delivery  of  polar  compounds 
utilizing dimethylether and propane as propellants. Pharm Dev Tech 
2000; 5:219-230. 
25.  Kriwet  K,  Muller-Goymann  CC.  Diclofenac  release  from 
phospholipid drug systems and permeation through excised human 
stratum corneum. Int J Pharm 1995; 125:231-242.
26. Ho HO, Huang MC, Chen LC, Hsia A, Chen KT, Chiang HS, Spur BW, 
Wong PYK, Sheu MT. The percutaneus delivery of prostaglandin E1 
and its alkyl esters by microemulsions. Chin Pharm J 1998; 50: 257-
266. 
27.  Schmalfu  U,  Neubert  R,  Wohlrab  W.  Modification  of  drug 
penetration into human skin using microemulsions. J Control Release 
1997; 46:279-285.
28. Cleland JL, Daugherty A, Mrysny R. Emerging protein delivery 
methods. Curr Opin Biotech 2001; 12: 212-219.
29. Burnside BA., Mattes CE, McGuinness CM, Rudnic EM, Belendiuk 
GW. Oral insulin delivery. US Patent 5824638, 1998.
30.  Owen  AJ,  Yiv  SH,  Sarkahian  AB.  Convertible  microemulsion 
formulations. US Patent 5444041A, 1997. 
31. Lianly IL, Nandi I, Kim KH. Development of an ethyl laurate based 
micro-emulsion for rapid onset of intranasal delivery of diazepam. Int J 
Pharm 2002; 237: 77-85.
Giri et al., Micro-Emulsion as a Novel Carrier for Drug Delivery 